Profiling Preexisting Antibodies in Patients Treated With Anti–PD-1 Therapy for Advanced Non–Small Cell Lung Cancer
Author:
Affiliation:
1. Department of Pulmonary Medicine, Sendai Kousei Hospital, Aoba-ku, Sendai, Miyagi, Japan
Publisher
American Medical Association (AMA)
Subject
Oncology,Cancer Research
Link
http:///jamaoncology/article-pdf/5/3/376/17345785/jamaoncology_toi_2018_oi_180104.pdf
Reference41 articles.
1. Association of pembrolizumab with tumor response and survival among patients with advanced melanoma.;Ribas;JAMA,2016
2. Pembrolizumab for the treatment of non-small-cell lung cancer.;Garon;N Engl J Med,2015
3. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms.;Parry;Mol Cell Biol,2005
4. Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation.;Bennett;J Immunol,2003
5. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.;Ishida;EMBO J,1992
Cited by 230 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Rapidly progressive interstitial lung disease with positive anti-MDA5 antibody as an immune-related complication of nivolumab: A case report;Respiratory Investigation;2024-03
2. Comprehensive multiplexed autoantibody profiling of patients with advanced urothelial cancer;Journal for ImmunoTherapy of Cancer;2024-02
3. Distinguishing immune checkpoint inhibitor-related pneumonitis from radiation pneumonitis by CT radiomics features in non-small cell lung cancer;International Immunopharmacology;2024-02
4. Unraveling the complex interplay between anti-tumor immune response and autoimmunity mediated by B cells and autoantibodies in the era of anti-checkpoint monoclonal antibody therapies;Frontiers in Immunology;2024-01-22
5. Pulmonary toxicity of immune checkpoint immunotherapy;Journal of Clinical Investigation;2024-01-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3